Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for HRMY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 667.79M
March 31, 2026 640.92M
December 31, 2025 775.34M
September 30, 2025 672.58M
June 30, 2025 565.27M
March 31, 2025 506.95M
December 31, 2024 467.19M
September 30, 2024 410.48M
June 30, 2024 346.91M
March 31, 2024 372.35M
December 31, 2023 353.46M
September 30, 2023 370.67M
June 30, 2023 370.98M
March 31, 2023 343.88M
Date Value
December 31, 2022 323.12M
September 30, 2022 307.76M
June 30, 2022 254.17M
March 31, 2022 224.50M
December 31, 2021 234.31M
September 30, 2021 189.70M
June 30, 2021 159.69M
March 31, 2021 141.17M
December 31, 2020 228.63M
September 30, 2020 221.74M
June 30, 2020 76.28M
March 31, 2020 71.52M
December 31, 2019 24.46M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Liquidia Corp. 284.18M
Repligen Corp. 810.45M
Johnson & Johnson 20.76B
ACADIA Pharmaceuticals, Inc. 956.47M
ANI Pharmaceuticals, Inc. 375.87M